Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting Wegovy for weight loss in the UK starts with a single step: a clinical assessment with a prescriber. Wegovy (semaglutide) is a prescription-only medicine, meaning no pharmacy can dispense it without one. The good news is that a regulated online pharmacy can carry out that assessment quickly, without a GP referral or a waiting list. Here is what the process actually involves, and what to think through before you begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've searched for how to get Wegovy for weight loss, you're probably past the curiosity stage. You've likely read enough to know this is a GLP-1 receptor agonist that reduces appetite by mimicking a gut hormone your body already produces. What you're deciding now is whether to pursue it, and through which route.
That's a reasonable place to feel a little uncertain. There's a lot of noise online, prices that seem too good to be true, sellers with no obvious medical oversight, and a gap between what the NHS offers and what's actually available to most people today.
The honest frame is this: Wegovy is a licensed medicine with a real evidence base. The STEP 1 trial, published in the New England Journal of Medicine, found an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. But it is a prescription medicine, clinical assessment comes first, and suitability varies from person to person. If you want to understand how it actually works in the body before going further, our explanation of how Wegovy works for weight loss covers the mechanism clearly.
The decision tree has two main branches: NHS access or private prescription. Both are legal and both require clinical oversight. What differs is speed, criteria, and cost.
Wegovy is available on the NHS, but access is narrow. NICE's appraisal of semaglutide (TA875) recommends it only when prescribed within a specialist weight management service offering multidisciplinary support, for a maximum of two years, and for adults with a BMI of 35 or above plus at least one weight-related comorbidity. Ethnic-background thresholds are typically 2.5 kg/m² lower under UK guidance.
Waiting lists for specialist weight management services are commonly long, and not every GP practice is actively referring into them. If your BMI sits between 27 and 34.9, the NHS route for Wegovy specifically may not be open to you at all, regardless of other health factors.
For a broader look at what's available and how the two routes compare, our Wegovy and weight loss overview sets it out plainly. The NHS is the right route if you meet the criteria and can wait; private prescription exists for everyone else who qualifies clinically.
Through a GPhC-registered online pharmacy, the eligibility is set by the medicine's UK licence. Adults with a BMI of 30 or above, or 27 or above with a qualifying weight-related condition, may be considered. A prescriber looks at the full picture (your medical history, current medicines, any contraindications) before making a decision. BMI alone does not guarantee a prescription; the clinical assessment is what matters.
At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, the same day it is submitted. There is no algorithm making the call. Photo ID and live weight verification happen as part of the process, and your GP is notified in line with GPhC guidance. You can verify our pharmacy on the official GPhC register at GPhC registration 9012878.
If you want to understand what the first few weeks look like practically, our guide to how you take Wegovy for weight loss walks through the dose schedule and what to expect. And if cost is part of your thinking, our Wegovy cost context page explains honestly what drives private pricing and what a legitimate service includes.
The demand for GLP-1 medicines has created a market for fake and illegally sold products. The MHRA has seized around 20 million doses of illegally traded weight-loss medicines, worth approximately £45 million, and raided the UK's first illicit site producing counterfeit tirzepatide pens. Fake pens have contained insulin rather than the labelled medicine, with serious consequences for people who received them.
Sellers offering Wegovy without requiring a prescription, social-media accounts advertising it at steeply discounted prices, and sites with no verifiable pharmacy registration are all warning signs. A legitimate regulated pharmacy will always require a clinical assessment, will appear on the GPhC pharmacy register, and will not offer a medicine at a price so far below the market rate that it raises obvious questions.
If you want to understand the semaglutide medicine itself in more depth before going further, our semaglutide information page covers the active ingredient clearly. And when you're ready to take the first step, you can speak to our prescribers through a free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.